166 related articles for article (PubMed ID: 31529663)
1. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
[TBL] [Abstract][Full Text] [Related]
2. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study.
Prasad K; Mohanty S; Bhatia R; Srivastava MV; Garg A; Srivastava A; Goyal V; Tripathi M; Kumar A; Bal C; Vij A; Mishra NK
Indian J Med Res; 2012 Aug; 136(2):221-8. PubMed ID: 22960888
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.
Taguchi A; Sakai C; Soma T; Kasahara Y; Stern DM; Kajimoto K; Ihara M; Daimon T; Yamahara K; Doi K; Kohara N; Nishimura H; Matsuyama T; Naritomi H; Sakai N; Nagatsuka K
Stem Cells Dev; 2015 Oct; 24(19):2207-18. PubMed ID: 26176265
[TBL] [Abstract][Full Text] [Related]
5. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke.
Yang B; Migliati E; Parsha K; Schaar K; Xi X; Aronowski J; Savitz SI
Stroke; 2013 Dec; 44(12):3463-72. PubMed ID: 24114454
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
[TBL] [Abstract][Full Text] [Related]
8. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.
Battistella V; de Freitas GR; da Fonseca LM; Mercante D; Gutfilen B; Goldenberg RC; Dias JV; Kasai-Brunswick TH; Wajnberg E; Rosado-de-Castro PH; Alves-Leon SV; Mendez-Otero R; Andre C
Regen Med; 2011 Jan; 6(1):45-52. PubMed ID: 21175286
[TBL] [Abstract][Full Text] [Related]
9. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
[TBL] [Abstract][Full Text] [Related]
10. Intravenous autologous bone marrow mononuclear cells for ischemic stroke.
Savitz SI; Misra V; Kasam M; Juneja H; Cox CS; Alderman S; Aisiku I; Kar S; Gee A; Grotta JC
Ann Neurol; 2011 Jul; 70(1):59-69. PubMed ID: 21786299
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-Analysis.
Cao W; Li P
Med Sci Monit; 2015 Jul; 21():2190-5. PubMed ID: 26215395
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells.
Cox CS; Hetz RA; Liao GP; Aertker BM; Ewing-Cobbs L; Juranek J; Savitz SI; Jackson ML; Romanowska-Pawliczek AM; Triolo F; Dash PK; Pedroza C; Lee DA; Worth L; Aisiku IP; Choi HA; Holcomb JB; Kitagawa RS
Stem Cells; 2017 Apr; 35(4):1065-1079. PubMed ID: 27800660
[TBL] [Abstract][Full Text] [Related]
14. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.
Osanai T; Houkin K; Uchiyama S; Minematsu K; Taguchi A; Terasaka S
Int J Stroke; 2018 Jun; 13(4):444-448. PubMed ID: 29134924
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.
Brenneman M; Sharma S; Harting M; Strong R; Cox CS; Aronowski J; Grotta JC; Savitz SI
J Cereb Blood Flow Metab; 2010 Jan; 30(1):140-9. PubMed ID: 19773802
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.
Kumar A; Prasad M; Jali VP; Pandit AK; Misra S; Kumar P; Chakravarty K; Kathuria P; Gulati A
Acta Neurol Scand; 2017 May; 135(5):496-506. PubMed ID: 27558274
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke.
Yang B; Strong R; Sharma S; Brenneman M; Mallikarjunarao K; Xi X; Grotta JC; Aronowski J; Savitz SI
J Neurosci Res; 2011 Jun; 89(6):833-9. PubMed ID: 21412816
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone-marrow mononuclear stem cell therapy in patients with stroke: a meta-analysis of comparative studies.
Chumnanvej S; Chumnanvej S
Biomed Eng Online; 2020 Sep; 19(1):74. PubMed ID: 32993677
[TBL] [Abstract][Full Text] [Related]
20. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
Hammadi AMA; Alhimyari F
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
